LBI-HTA - Publications - Search - Horizon Scanning in Oncology 37th Prioritization – 4th quarter 2018

Grössmann, N. and Rothschedl, E. and Wolf, S. (2018): Horizon Scanning in Oncology 37th Prioritization – 4th quarter 2018. HSO: 37th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
1083Kb
Abstract

For the 37th prioritisation (October 2018), 14 drugs were filtered out of 477 identified and were sent to prioritisation. Of these, 6 drugs were ranked as 'highly relevant' by the expert panel, 7 as 'relevant' and 1 as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:English
Series Name:HSO: 37th Prioritisation
Deposited on:11 Oct 2018 16:16
Last Modified:11 Oct 2018 16:16

Repository Staff Only: item control page